Latham & Watkins LLP has advised Remix Therapeutics. Fenwick & West LLP has advised Passage Bio. Cooley LLP has advised Goldman Sachs & Co. LLC, Jefferies...
Remix Therapeutics and Passage Bio Announce Merger and $100 Million Private Placement
Odyssey Therapeutics Announces $304 Million Upsized IPO and Private Placement
Covington and Wilson Sonsini have advised Odyssey Therapeutics. Cooley has advised the underwriters. Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on autoimmune and inflammatory diseases,...
Dianthus Therapeutics Closes $288 Million Public Offering of Common Stock and Pre-Funded Warrants
Gibson Dunn and Goodwin Procter has advised Dianthus Therapeutics, Inc., while Cooley has represented the underwriters. Dianthus Therapeutics, Inc., a clinical-stage biotechnology company focused on antibody...
Voyager Therapeutics’ $100 Million Common Stock Offering
Wilmer Cutler Pickering Hale and Dorr advised Voyager Therapeutics, Inc. on the offering, and Cooley advised the underwriters. Voyager Therapeutics, Inc. (Nasdaq: VYGR) announced an underwritten public offering...
Argenx’s $1.27 Billion Follow-On Offering
Goodwin and Freshfields advised argenx, while Cooley advised the representatives of the several underwriters on the offering. argenx SE closed its $1.27 billion follow-on offering. On July 19,...
Structured Alpha’s Acquisition of Liminal BioSciences
Torys is serving as legal advisor to Structured Alpha, while Stikeman Elliot and Cooley are serving as Liminal BioSciences’ legal advisors. Liminal BioSciences Inc. (NASDAQ: LMNL) and...
BowX Acquisition Corp.’s Merger With WeWork
Cooley LLP advised BowX Acquisition Corp. on the deal while Morrison & Foerster LLP represented SoftBank Group Corp. Willkie Farr & Gallagher LLP advised Insight Partners...